Bone Growth Stimulators Market Expected To Generate Revenue Of $1.66B By 2028, Globally, With A CAGR Of 6.08%: Verified Market Research®

Bone Growth Stimulators Market Expected To Generate Revenue Of .66B By 2028, Globally, With A CAGR Of 6.08%: Verified Market Research®

The main factors driving the growth of the bone growth stimulators market are an increase in the propensity of patients for minimally invasive and non-invasive surgical procedures, and the availability of affordable bone growth stimulation devices.

JERSEY CITY, NJ, November 8, 2022 /PRNewswire/ — Verified Market Research recently released a report, “Bone Growth Stimulators MarketBy product (bone growth stimulation devices, bone morphogenetic proteins, platelet-rich plasma), by application (spinal fusion surgeries, nonunion and delayed union bone fractures, oral and maxillofacial surgeries), by geographic scope, and prognosis.

According to in-depth research by Verified Market Research, the global Bone Growth Stimulator market size was valued at $1.04 billion in 2020 and is projected to reach $1.66 billion by 2028, growing at a CAGR of 6.08% from 2021 to 2028.

Download brochure in PDF:

Explore OCD in depth inBone Growth Stimulators Market

202 – Pages
126 – Tables
37 – Figures

Overview of Global Bone Growth Stimulator Market

Doctors recommend bone growth stimulator therapy to help after a fracture or spinal fusion surgery to help fractures repair more quickly. They are also called orthogenesis stimulators and they deliver painless ultrasound. In cervical and lumbar spine surgeries they are of great help. Products made from platelet-rich plasma and bone morphogenetic protein (BMP) promote bone development when used to treat various fractures and spinal operations.

As a result of faster recovery after these surgeries, the use of these products is expected to increase. Therefore, more orthopedic and spinal procedures are being performed as the number of accident and trauma patients increases. This rise has further increased consumer demand for these products, along with those for BMP and PRP, which is expected to fuel the expansion of the market.

Increased geriatric population, increased fracture and accident rates, increased prevalence of arthritis, increased incidence of diabetes and other diseases such as vascular disease, obesity, and kidney disorders, increased patient preference for procedures minimally invasive and non-invasive surgical procedures, increase in platelet-rich plasma and bone morphogenetic proteins, and the increase in the availability of bone growth stimulation devices at reasonable prices are the main factors.

Other factors contributing to the growth of the bone growth stimulators market include the increase in patient awareness of bone growth stimulators, the procedural benefits provided by bone growth stimulation devices in the treatment of bone fractures and orthopedic diseases, the increase in technological advances in bone growth stimulators, and the increase in the rate of adoption of bone growth stimulators by both patients and prescribers. However, market expansion is anticipated to be limited by strict approval procedures and limited medical reimbursement regulations.

It has been seen that the general expansion of the market is hampered by frequent product recalls. A manufacturer’s business and reputation suffer when products are recalled. This can also have an impact on a customer’s engagement with other items from a company. Recalls often cast doubt on the effectiveness of novel products, delaying their acceptance by surgeons.

key developments

  • In July 1, 2021, ICelularity Inc. (“Celularity”), a clinical biotechnology company that develops new ways to treat cells and biomaterial products found in the human placenta after birth to treat cancer, infectious and degenerative diseases, and Arthrex, Inc. ., a world leader in orthopedic technology, announced that the companies have entered into a special partnership to distribute and sell Celularity’s biomaterial products for orthopedic surgery and sports medicine. Under the terms of the agreement, Celularity will provide Arthrex with exclusive distribution rights for orthopedic surgery and sports medicine and will remain responsible for the production and supply of products.
  • In January 5, 2021, Sryker announced the acquisition of OrthoSensor, Inc., a private company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital transformation of musculoskeletal care and sensory replacement technology.

key players. main players

The main market players are Arthrex, Inc., Essex Woodlands Healthcare Partners (Bioventus LLC), Colfax Corporation (DJO Global, Inc), Isto Biologics, Johnson & Johnson (Depuy Synthes), Medtronic Plc, Orthofix Medical Inc., Stryker Corporation, Terumo Corporation, and Zimmer Biomet holdings, inc.

Verified Market Research has segmented the global Bone Growth Stimulator Market on the basis of product, application, and geography.

  • Bone Growth Stimulators Market, by Product
    • Bone Growth Stimulation Devices
    • Bone morphogenetic proteins
    • platelet rich plasma
  • Bone Growth Stimulator Market, By Application
    • spinal fusion surgeries
    • Delayed Union and Nonunion Bone Fractures
    • Oral and Maxillofacial Surgeries
    • Others
  • Bone Growth Stimulators Market, By Geography
    • North America
    • Europe
      • Germany
      • France
      • United Kingdom
      • The rest of Europe
    • Pacific Asia
      • Porcelain
      • Japan
      • India
      • The rest of Pacific Asia
    • ROW
      • middle East & Africa
      • Latin America

Explore related reports:

Bone graft and substitute market By type (allograft, bone graft substitute), by application (craniomaxillofacial, dental bone graft), by geography, and prognosis

Demineralized Bone Matrix Market By type of product (gel, putty), by application (dental, craniomaxillofacial), by end user (hospitals, specialized clinics), by geography and forecast

Orthobiological market By product (viscosupplementation products, allografts, plasma-rich proteins, demineralized bone matrix), by end user (orthopedic hospitals and clinics, dental clinics, academic and research institutes), by geography and forecast

Orthopedic bone cement material market By product (polymethylmethacrylate cement, calcium phosphate cement), by application (hospital, clinic), by geography, and forecast

Top Consumer Healthcare Companies improving the lives of consumers from pole to pole

Visualize the Bone Growth Stimulator Market using verified market intelligence:

Verified market intelligence it’s ours BI-enabled platform for storytelling in this market. IMV offers detailed forecast trends and accurate information on more than 20,000 emerging and niche markets, helping you make critical decisions that impact revenue for a bright future.

IMV provides a holistic overview and global competitive landscape with respect to region, country, segment, and key players in its market. Present your market report and findings with a built-in presentation feature that saves over 70% of your time and resources for investor presentations, sales and marketing, R&D, and product development. IMV allows the delivery of data in Excel and interactive PDF format with more than 15 key market indicators for your market.

About us

Verified Market Research is a leading global research and consulting firm serving more than 5,000 clients. Verified Market Research provides advanced analytical research solutions while delivering information-rich research studies. We provide insights on strategic and growth analysis, data needed to achieve corporate objectives, and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and the use of industry governance techniques to collect and analyze data in more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, experience, and years of collective experience to produce informative and accurate research.

We study more than 14 categories of semiconductors and electronics, chemicals, advanced materials, aerospace and defense, energy and power, health, pharmaceuticals, automotive and transportation, information and communication technology, software and services, information security, mining, minerals and metals, construction and construction, agricultural industry and medical devices from more than 100 countries.

Contact Us

Mister. edwyne fernandes
Verified Market Research®
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
Asia-Pacific: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Follow us: LinkedIn | Twitter


SOURCE Verified Market Research

Leave a Comment